GlassScriptPhysician profile
Tran To
NPI 1386319481
$2,243.62
in general payments reported to CMS, 2019-2025
17 companies · $606 in 2025
The $606 reported for 2025 was more than what 77% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $131 · 2022: $696 · 2023: $494 · 2024: $316 · 2025: $606.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,416.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,416.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $467.72 | 2022-2023 | Relistor |
| Collegium Pharmaceutical, INC. | $375.48 | 2021-2023 | Belbuca, Xtampza |
| Teleflex LLC | $288.66 | 2024-2025 | Urolift, Barrigel |
| Janssen Scientific Affairs, LLC | $274.82 | 2025 | Erleada |
| Procept Biorobotics Corporation | $168.84 | 2025 | |
| C. R. Bard, INC. & Subsidiaries | $156.56 | 2024 | Bard Urinary Drainage Bag |
| Scilex Pharmaceuticals INC. | $123.85 | 2021-2023 | Ztlido |
| Boston Scientific Corporation | $118.86 | 2022-2025 | General - Pain Management |
| Abbvie INC. | $71.89 | 2022 | |
| Almatica Pharma LLC | $45.84 | 2022-2023 | Gralise |
| Teva Pharmaceuticals USA, INC. | $42.04 | 2022 | |
| Redhill Biopharma INC. | $29.03 | 2021-2022 | |
| Nalu Medical, INC. | $22.77 | 2021 | |
| Pfizer INC. | $17.61 | 2023 | |
| Arbor Pharmaceuticals, INC. | $13.81 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $13.31 | 2022 | |
| Grt US Holding, INC. | $12.53 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tran To listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.